submit urlsubmit rss feedadd directoryphysician directoryPharmacology opportunity

article

Zolmitriptan is an oral, selective 5-hydroxytryptamine 1B/1D (5-HT 1B/1D ) receptor agonist. It is a second-generation triptan, for acute treatment of migraine attacks with or without aura and cluster headaches.

Zolmitriptan is marketed by AstraZeneca with the brand names Zomig, Zomigon (Greece & Argentina) and AscoTop (Germany).

Description


Zolmitriptan is a synthetic indole derivative with the empirical formula is C16H21N3O2. Zolmitriptan is a white to almost white powder that is readily soluble in water.

More on [ Zolmitriptan ]


directory of related categories

 
Zolmitriptan RSS feed
Zolmitriptan - Twitter Search

if you are currently taking an ssri and you have a migraine …: Zomig (zolmitriptan) 5 mg. And, unlike Imitrex, .. http://bit.ly/BJsVS
authornley (Norwort Princeton) Wed, 18 Nov 2009 01:50:45 -0000
if you are currently taking an ssri and you have a migraine …: Zomig (zolmitriptan) 5 mg. And, unlike Imitrex, .. http://bit.ly/BJsVS

 
Subscribe to Zolmitriptan RSS feed

directory of related sites

DrugDigest: Zolmitriptan - Information on dosage, usage, side effects, interactions, and drug comparisons including generics when available.

MEDLINEplus: Zolmitriptan - Features information about dosage, usage, warnings, and side effects.
Meta Description: [ Zolmitriptan (Systemic) ]

Zomig - Features information for US consumers and health care professionals, including detailed migraine information.
Meta Description: [ For migraine headache relief, you can rely on ZOMIG� (zolmitriptan). This AstraZeneca ZOMIG� migraine relief Web site offers information on treatment of migraine headache for patients and physicians. ]

Zolmitriptan related videos
Nostril Errors with Nasal Sprays (Oct. 2006)
Zolmitriptan related videos

 

HOMEADVERTISINGABOUT US

articlesartsbusinesscomputersgameshealthhospitalshomekids & teensnewsmobilephysiciansrecreationreferenceregionalscienceshoppingsocietysportsworld


Submit a Site About Become an Editor